Akshay Navaladi
About Akshay Navaladi
Data last updated:
Akshay Navaladi has 11 years in corporate governance. Holds Director and Designated Partner roles. Currently with 6 companies, including Fenway Pharmaceuticals Private Limited and Disruptive Health Solutions Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Fenway Pharmaceuticals Private Limited U24239DL2021PTC382105 | Director | 09 Jun 2021 | 2021 | Active |
 Disruptive Health Solutions Private Limited U85100DL2014PTC274801 | Director | 30 Dec 2014 | 2014 | Active |
| Himalayan Tennis Private Limited U93120DL2024PTC434164 | Director | 15 Jul 2024 | 2024 | Active |
| Grahasrx Pharmaceutical Private Limited U21002DL2024PTC432610 | Director | 12 Jun 2024 | 2024 | Active |
| Anam Ventures Private Limited U86909HR2023PTC112581 | Director | 12 Jun 2023 | 2023 | Active |
| Ansm Ventures Llp ACB-5377 | Designated Partner | 08 Jun 2023 | 2023 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akshay Navaladi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akshay Navaladi
Akshay Navaladi has 11 years in corporate governance. Holds Director and Designated Partner roles. Currently with 6 companies, including Fenway Pharmaceuticals Private Limited and Disruptive Health Solutions Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Akshay Navaladi is associated with 6 companies as Director and Designated Partner.
Akshay Navaladi has expertise in General Business, Healthcare.
Akshay Navaladi has 11 years in corporate governance.